S100A11 (calgizzarin), a member of S100 family, is associated with several autoimmune diseases, including rheumatoid arthritis (RA). Neutrophil extracellular traps (NETs) are implicated in the pathogenesis of RA and in the externalization of some S100 family members. Therefore, we aimed to determine the association between S100A11 and NETs in RA. For this purpose, the levels of S100A11 and NETosis markers were detected in the RA synovial fluid by immunoassays. The expression of S100A11 by neutrophils in the RA synovial tissue was assessed. Neutrophils isolated from peripheral blood were exposed to S100A11 or stimulated to release NETs. The levels of NETosis- and inflammation-associated proteins were analysed by immunoassays. NETs were visualized by immunofluorescence. We showed that S100A11 was expressed by the neutrophils in the RA synovial tissue. Moreover, S100A11 in the RA synovial fluid correlated with several NETosis markers. In vitro, S100A11 was abundantly released by neutrophils undergoing NETosis compared to untreated cells (p < 0.001). Extracellular S100A11 increased the secretion of IL-6 (p < 0.05) and TNF (p < 0.05) by neutrophils but did not induce NETosis. This study demonstrates, for the first time, that the release of S100A11 is dependent on NETosis and that extracellular S100A11 augments the inflammatory response by inducing pro-inflammatory cytokines in neutrophils.

1st Orthopaedic Clinic 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Rheumatology 1st Faculty of Medicine Charles University Prague Czech Republic

Institute for Inflammation Research Center for Rheumatology and Spine Diseases Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

Institute of Rheumatology Na Slupi 4 12850 Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc22004533

003      

CZ-PrNML

005      

20220127145154.0

007      

ta

008      

220113s2021 xxk f 000 0|eng||

009      

AR

024    7_

$a 10.1038/s41598-021-85561-3 $2 doi

035    __

$a (PubMed)33727634

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Navrátilová, Adéla $u Institute of Rheumatology, Na Slupi 4, 12850, Prague, Czech Republic $u Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

245    10

$a S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils / $c A. Navrátilová, V. Bečvář, J. Baloun, D. Damgaard, CH. Nielsen, D. Veigl, K. Pavelka, J. Vencovský, L. Šenolt, L. Andrés Cerezo

520    9_

$a S100A11 (calgizzarin), a member of S100 family, is associated with several autoimmune diseases, including rheumatoid arthritis (RA). Neutrophil extracellular traps (NETs) are implicated in the pathogenesis of RA and in the externalization of some S100 family members. Therefore, we aimed to determine the association between S100A11 and NETs in RA. For this purpose, the levels of S100A11 and NETosis markers were detected in the RA synovial fluid by immunoassays. The expression of S100A11 by neutrophils in the RA synovial tissue was assessed. Neutrophils isolated from peripheral blood were exposed to S100A11 or stimulated to release NETs. The levels of NETosis- and inflammation-associated proteins were analysed by immunoassays. NETs were visualized by immunofluorescence. We showed that S100A11 was expressed by the neutrophils in the RA synovial tissue. Moreover, S100A11 in the RA synovial fluid correlated with several NETosis markers. In vitro, S100A11 was abundantly released by neutrophils undergoing NETosis compared to untreated cells (p < 0.001). Extracellular S100A11 increased the secretion of IL-6 (p < 0.05) and TNF (p < 0.05) by neutrophils but did not induce NETosis. This study demonstrates, for the first time, that the release of S100A11 is dependent on NETosis and that extracellular S100A11 augments the inflammatory response by inducing pro-inflammatory cytokines in neutrophils.

650    _2

$a dospělí $7 D000328

650    _2

$a senioři $7 D000368

650    _2

$a revmatoidní artritida $x metabolismus $x patologie $7 D001172

650    _2

$a extracelulární pasti $x metabolismus $7 D065206

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a interleukin-6 $x metabolismus $7 D015850

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    _2

$a neutrofily $x metabolismus $x patologie $7 D009504

650    _2

$a proteiny S100 $x metabolismus $7 D009418

650    _2

$a synoviální tekutina $x metabolismus $7 D013582

650    _2

$a TNF-alfa $x metabolismus $7 D014409

655    _2

$a klinické zkoušky $7 D016430

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Bečvář, Viktor $u Institute of Rheumatology, Na Slupi 4, 12850, Prague, Czech Republic

700    1_

$a Baloun, Jiří $u Institute of Rheumatology, Na Slupi 4, 12850, Prague, Czech Republic

700    1_

$a Damgaard, Dres $u Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

700    1_

$a Nielsen, Claus Henrik $u Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

700    1_

$a Veigl, David $u First Orthopaedic Clinic, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Pavelka, Karel $u Institute of Rheumatology, Na Slupi 4, 12850, Prague, Czech Republic $u Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Vencovský, Jiří $u Institute of Rheumatology, Na Slupi 4, 12850, Prague, Czech Republic $u Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Šenolt, Ladislav $u Institute of Rheumatology, Na Slupi 4, 12850, Prague, Czech Republic $u Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Andrés Cerezo, Lucie $u Institute of Rheumatology, Na Slupi 4, 12850, Prague, Czech Republic. andres-cerezo@revma.cz $u Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. andres-cerezo@revma.cz

773    0_

$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 11, č. 1 (2021), s. 6063

856    41

$u https://pubmed.ncbi.nlm.nih.gov/33727634 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20220113 $b ABA008

991    __

$a 20220127145150 $b ABA008

999    __

$a ok $b bmc $g 1751861 $s 1155682

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2021 $b 11 $c 1 $d 6063 $e 20210316 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195

LZP    __

$a Pubmed-20220113